To study the roles of viral genes in the establishment and maintenance of herpes simplex virus (HSV) latency, we have developed a polymerase chain reaction assay that is both quantitative and sensitive. Using this assay, we analyzed the levels of viral DNA in trigeminal ganglia of mice inoculated corneally with HSV mutants that are defective for virus replication at one or more sites in mice and for reactivation upon ganglionic explant. Ganglia from mice infected with thymidine kinase-negative mutants, which replicate at the site of inoculation and establish latency but do not replicate acutely in ganglia or reactivate upon explant, contained a range of levels of HSV DNA that overlapped with the range found in ganglia latently infected with wild-type virus. On average, these mutant-infected ganglia contained one copy of HSV DNA per 100 cell equivalents (ca. 10 molecules), which was 50-fold less than the average for wild-type virus. Ganglia from mice infected with a ribonucleotide reductase deletion mutant, which is defective for acute replication and reactivation upon ganglionic explant, also contained on average one copy of HSV DNA per 100 cell equivalents. We also detected substantial numbers of HSV DNA molecules (up to ca. 103) in ganglia of mice infected with an ICP4 deletion mutant and other replication-negative mutants that are severely impaired for viral DNA replication and gene expression. These results raise the possibility that such mutants can establish latency, which could have important implications for mechanisms of latency and for vaccine and antiviral drug development.
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Herpesviruses, like retroviruses, papillomaviruses, and hepadnaviruses, establish latent infections in their hosts, forming lifelong reservoirs of recurrent disease that resist cure (1) . Herpes simplex virus (HSV) latency (12, 27 ) is preceded by productive infection at the periphery of a mammalian host. The virus enters nerve endings and migrates to ganglionic nuclei, where productive infection can again ensue. With time, latency develops, in which viral DNA (9, 23) but no infectious virus is present. However, infectious virus can be reactivated by certain stimuli or by explant of ganglia.
The roles of productive infection processes in the establishment and maintenance of HSV latency have not been determined. Considerable understanding of the productive infection cycle of HSV and the roles of specific genes has been gained through the use of engineered mutants with defects in functions important for virus replication and gene expression (24) . When such replication-defective mutants have been tested in a mouse model of latency, they have failed to reactivate from explanted ganglia (14, 16 ). It has not been possible to determine whether the failure of these mutants to reactivate is due solely to the replication defect during reactivation or also to a requirement for specific viral productive infection processes in the establishment and maintenance of latency. Such processes could include DNA replication or steps in the regulatory cascade of virus gene expression.
Certain mutants that are replication competent in cell culture fail to reactivate from explanted ganglia in a mouse model. These include thymidine kinase-negative (tk-) mutants and certain thymidine kinase-deficient mutants. These mutants do establish and maintain latency, as evidenced by * Corresponding author. expression of latency-associated transcripts (5, 17, 29) and their ability to rescue replication-negative virus following superinfection of dissociated ganglia (5) or to be rescued by superinfection with wild-type virus (8) MATERIALS AND METHODS Cells and viruses. The viruses used in this study are listed in Table 1 . The wild-type strain was HSV type 1 KOS, which was propagated and assayed on Vero cells, maintained as described previously (31) . Mutants dlsptk and dlsactk (5) engineered to contain 360-and 4-base-pair deletions in the HSV tk gene, respectively, were propagated and titers were determined on Vero cells. Mutant ICP6A (11) contains a 2.9-kilobase-pair deletion in the gene encoding ICP6, the large subunit of HSV ribonucleotide reductase. This mutant and the D14 cells (10) on which it was propagated and its titer determined were kindly provided by D. Goldstein and S. Weller. High-titer stocks of mutants d120 and n12, which contain a 4. 1-kilobase-pair deletion and a nonsense mutation in the gene encoding ICP4, respectively (6, 7) , were generously provided by N. DeLuca and P. Schaffer. A high-titer TAACAGCGTCAACAGCGT and CAAAGAGGTGCGGG AGT, was specific for the HSV tk gene (13, 19, 30) and the other, AGTGTGCGGGGATGCAGT and ACGCGAGAGC CCCACGTA, was specific for the single-copy mouse adipsin gene (20) . These DNAs were then assembled into 100-,l reactions containing 50 mM KCl, 10 mM Tris chloride (pH 8.4), 4.5 mM MgCI2 (which was found to be optimal for this primer-template combination), 100 ,ug of gelatin per ml, 200 ,uM concentrations of each deoxynucleoside triphosphage, and 4 U of Taq DNA polymerase. PCR amplification was then performed for 30 cycles, with denaturation for 1 min at 94°C, annealing for 2 min at 55°C, and extension for 3 min at 72°C, with a final additional extension of 7 min.
Analysis of PCR products. A 10-pl portion from each PCR amplification was electrophoresed on a 12% nondenaturing polyacrylamide gel, visualized by ethidium bromide staining, transferred to a nylon filter (Gene-Screen Plus; New England Nuclear-Dupont), and UV cross-linked as described before (2) . The filter was then prehybridized at 50°C for 2 (13, 19, 30) and the other was specific for the single-copy mouse gene adipsin (20) . The 100 ng of mouse tail DNA alone and 100 ng of DNA from each of two trigeminal ganglia of mock-infected mice were also included. These samples were amplified by PCR, using oligonucleotide primers specific for a portion of the HSV tk gene and a second set of primers specific for the mouse adipsin gene. The PCR products were electrophoresed on a polyacrylamide gel alongside radiolabeled Hinfi-digested (X174 DNA, which served as size markers. The DNA was transferred to a nylon filter and probed with a radiolabeled oligonucleotide specific for the HSV PCR product. (Bottom) Detection of the internal control mouse PCR product. The PCR products shown were analyzed by stripping the filter and probing with an oligonucleotide specific for the mouse adipsin gene PCR product.
( Fig. 1, top) . In contrast, the PCR signal corresponding to the mouse adipsin product, which could be visualized routinely by ethidium bromide staining (not shown), remained relatively constant. This is shown as detected by probing with an appropriate radiolabeled primer (Fig. 1, bottom) . When densitometric analysis of the HSV signal from similar reconstruction experiments was performed, a nearly linear log-log relationship between signal intensity and the amount of viral DNA was obtained (see Fig. 3B for an example). This empirically derived relationship was convenient in permitting analysis of a wide range of amounts of HSV DNA.
The assay could readily detect amounts of HSV DNA mixed with mouse DNA at 10-4 copies per cell equivalent (most obvious in Fig. 2B ), which corresponds to two molecules of HSV DNA (based on Poisson distribution principles, it is fairer to say that the amount of HSV DNA present in this mixture is one or a few molecules). A zero-copy reconstruction control and ganglionic DNA prepared from two mock-infected mice yielded similar mouse adipsin signals, but no detectable HSV-specific signal (Fig. 1) Fig. 2A, Table 1 ). This variation evidently is a property of the ganglia themselves; it could not be ascribed to variability in the PCR assay as repeat assays of different samples from individual ganglia yielded similar results (not shown). Both the average value and the range were very similar to those obtained for ganglia of CD-1 mice following corneal inoculation with wild-type strain KOS, using slot-blot hybridization methods (16) . Figure 2B shows (5) . They do not reactivate upon ganglionic explant, but do establish latent infections, as evidenced by expression of latency-associated transcripts and their ability to rescue replication-negative virus following superinfection of dissociated ganglia (5) . As expected from these results, ganglia from mice latently infected with the tk-mutants contained substantial numbers of HSV DNA molecules, ranging up to 0.1 copy per cell (ca. 105 molecules per ganglion) (Fig. 2B) . Although, as was the case with wild-type virus, there was substantial variation in the amounts of HSV DNA in individual ganglia, the average amount of HSV DNA present in ganglia of mice infected with either tk-mutant was 0.01 copy per cell (Table 1) . Thus, the average amount of DNA in ganglia from tkmutant-infected mice was less than that from KOS-infected mice, but the ranges of values overlapped. Quantification of DNA from mice infected with a ribonucleotide reductase mutant. Figure 3 shows the results obtained with ganglia from mice infected with mutant ICP6A. This deletion mutant fails to specify HSV ribonucleotide reductase activity (11) . Although it can replicate in many cell types in culture (11), it is highly defective for replication in mouse cells at 38°C (14) . Following corneal inoculation, ICP6A replicates very poorly in the eye, achieving barely detectable titers. It fails to achieve detectable titers in trigeminal ganglia during the 4 days following inoculation or to reactivate from these ganglia upon explant 30 days after inoculation (14 (Fig. 3 , Table 1 ). Thus, minimal replication at the site of inoculation suffices for tens of thousands of viral DNA molecules to reach the trigeminal ganglion and be maintained there stably. ICP4, ICP27, and pol mutants. Based on these results, we next asked whether any viral replication is necessary for viral DNA to reach the trigeminal ganglion and be maintained there. We therefore tested several mutants that are replication negative because of defects in viral gene expression and DNA replication. These mutants include d120 (6), which contain a large deletion in the gene encoding the major regulatory protein, ICP4; n12 (7), which contains a nonsense mutation in the ICP4 gene; d27-1 (22) virus is present in stocks of these mutants (6, 22 ; N. DeLuca, S. Rice, and D. Knipe, personal communications).
Despite the severe defects of the mutant viruses, HSV DNA could be detected readily in ganglia from mice infected 30 days or more previously with the mutants (Fig. 4, Table  1 ). As stated previously, data were used only from experiments such as that shown in Fig. 4 in which all negative controls (at least three per experiment) gave no HSV signal, but gave similar mouse adipsin signals (not shown). Different aliquots of ganglionic DNA from mice infected with these mutants could contain no detectable DNA or varying amounts of DNA. In particular, up to 0.001 copy per cell (ca.
103 molecules per ganglion) was found in the ganglia of mice that had been infected with d120 (Fig. 4) . Repeated analyses of DNA from specific ganglia revealed that certain samples that scored negative in one PCR assay often scored positive in others, which would be expected from a Poisson distribution of HSV DNA molecules among aliquots of ganglionic DNA. Taking into account all of the assays, levels of HSV DNA averaging 0.0001 copy per cell (ca. 102 molecules per ganglion) were detected in ganglia of mice that had been infected with any of the replication-negative mutants.
DISCUSSION
We describe here the development of a quantitative PCR assay for HSV DNA and its use in quantifying DNA in ganglia of mice infected with HSV mutants. As summarized in Table 1 , we found substantial amounts of HSV DNA not only in ganglia of mice infected with tk-mutants known to establish latent infections (5) The indicated mixtures of HSV DNA and uninfected mouse DNA and samples of trigeminal ganglion DNA from mock-infected mice or mice infected with HSV mutant d120, n12, or d27-1 were analyzed as described in the legend to Fig. 1. even in mice infected with replication-negative mutants. Below we discuss aspects of the quantitative PCR assay, how the amounts of HSV DNA found in ganglia relate to biological properties of the tk-and ICPA mutants, and the possible implications for mechanisms of latency and for vaccine and antiviral drug development of our finding of HSV DNA in ganglia of mice infected with replicationnegative mutants.
Quantitative PCR assay for HSV DNA. To develop the quantitative PCR assay, the most important modifications to the standard assay (25) were optimizing the MgCl2 concentration, increasing the amount of DNA polymerase, and limiting the amount of template DNA. These and other parameters are discussed in more detail elsewhere (3). Under the conditions described here, the nearly linear log-log relationship between autoradiographic signal and amount of DNA in the range of roughly 10-4 and 1 copy per cell sometimes breaks down above 10' copy per cell; however, decreasing the number of PCR cycles allows linearity in the range of 10-1 through 10 copies per cell (E. Pelosi and D. Coen, unpublished results).
For ganglia from mice infected with wild-type virus ( Fig.  2A , Table 1 ) and for ICP0 deletion mutants (not shown), we obtained values for HSV DNA content with the PCR assay that were very similar to those obtained with slot blot hybridization (16) . These results also help establish the validity of the PCR assay. The PCR assay was nevertheless far more sensitive than slot blot hybridization, with which it was difficult to distinguish signal from background below 0.01 to 0.1 copy per cell (16) and which failed to determine whether ganglia from mice infected with mutant n12 contained HSV DNA (16) . The PCR assay answered that question (Fig. 4) .
The use of PCR to detect viral nucleic acids in clinical specimens is growing rapidly. Two features of the assay described here may be useful in clinical settings. The internal control (in clinical specimens this could be a single-copy human gene) is invaluable both in eliminating false-negatives and in aiding quantification. The quantitative assay is helpful in assessing the presence of contaminating sequences and the likelihood that a positive result is due to contamination. In our hands, when contamination occurred, it was usually at the level of one or a few molecules per sample, which would be easy to distinguish from true positives in many clinical situations.
After the present study was completed, a PCR assay to quantify human immunodeficiency virus DNA was reported (21) . This assay, which uses end-labeled PCR primers and thus does not require blotting and hybridization steps, appeared to be as quantitative as the assay described here, but somewhat less sensitive and more likely to detect nonspecific products.
Levels of HSV DNA in ganglia latently infected with tkmutants. Our finding that the ranges of the amounts of DNA found in ganglia of mice infected with wild-type strain KOS and the tk-mutants overlapped supports our previous conclusion (5) that these mutants establish latency. Nevertheless, there was on average 50-fold less DNA per ganglion from the mutant-infected mice than from wild-type-infected mice. In contrast, in situ hybridization experiments detected three-to fivefold fewer latency-associated transcript-positive cells in tk-mutant latently infected ganglia than in those of wild type (5) . The autoradiographic signal per cell was similar between KOS and tk-mutant-infected ganglia (5); still, there could be fewer HSV genomes per cell in mutantinfected ganglia. It is also possible that more HSV DNA is found in non-neuronal cells in KOS-infected ganglia than in mutant-infected ganglia. These possibilities are under investigation. Two (12) . Based on the discussion above, we suggest that this is due solely to decreasing the number of virus genomes that are capable of establishing latent infections. Our results therefore lead to the speculation that chemotherapeutic or immunoprophylactic strategies targeted against lytic functions of the virus may be unable to prevent latency completely.
